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ABSTRACT 
Tamaka svasa is a Vatakaphaja vyadhi, originating from Pittasthana and manifested through 
Pranavaha Srotas. Vata get obstructed by Kapha dosha and travels into Pratiloma gati (opposite 
direction) and in turn causes Svasa (Dyspnoea). Its clinical features resembles with Bronchial asthma. 
Objectives: The study was carried out to assess the role of Virecana karma in the management of 
Tamaka svasa with Trivrutadi Modaka. Materials and methods: The clinical study was conducted at 
Dr.B.R.K.R.Govt. Ayurvedic Hospital and Research Centre, Erragadda, Hyderabad. 30 patients of either 
sex fulfilling the clinical criteria for diagnosis of Tamaka svasa (bronchial asthma) were selected in 
accordance with following inclusion & exclusion criteria. Murchita Tilataila was given for Snehapana 
and the Virecana yoga was Trivrutadi Modaka. The result was assessed at every 15 days. Subjective 
and objective parameters were analyzed before and after the treatment. Results: There was moderate 
relief in 23 Patients (76.66%), Marked relief in 4 Patients (13.33%) and 3 Patients (10.00%) showed 
mild relief, Complete remission was not found. Conclusion: Virecana karma (Purgative Therapy) has 
given maximum effect to pacify the almost entire range of signs and symptoms associated with the 
disease and by reducing its frequency, severity, emergency drug usage and there by providing quality 
life to the patients.  
KEY WORDS: Tamaka Svasa, Bronchial Asthma, Virecana karma, Murchita Tilataila, Trivrutadi 
Modaka. 
INTRODUCTION 
Dalhanacharya described Svasa (dyspnoea) as 
“kruchram svasam karoti iti svasam” means, difficulty 
in taking breath is known as Svasa. There are 5 types 
of Svasa mentioned in Ayurveda1,2,3, Tamaka Svasa is 
one among them. Tamaka Svasa is Vatakaphaj vyadhi, 
originating from Pittasthana4 and manifested through 
Pranavaha Srotas. Vata gets obstruction by Kapha and 
travels into Pratiloma gati and in turn causes Svasa.  
At initial stage, it is said to be curable, but in 
chronic cases, it becomes Yapya5 (manageable 
disease). Its clinical features resembles Bronchial 
Asthma.  
Modern medicine also considers, Asthma as a 
manageable disease, and providing various drugs, but 
those are giving only symptomatic relief and their 
continuous usage not only proved to be in-effective, 
but also causing serious side effects. So, the main aim 
of treatment in this disease is to reduce the intensity, 
frequency and duration of exacerbation to the 
minimum and to provide quality life to the patient.  
Pancha karma (bio-purification therapy) is the 
best way to treat these types of chronic diseases 
effectively & safely without any drug dependency. It 
also detoxifies the body, by which Bala (immunity) can 
also be enhanced, there by decreases the recurrence of 
the disease.  
In Tamaka Svasa, Virecana karma (purgation 
therapy) has described by Carakacharya, as “Vata 
sleshma harairyuktam tamake tu virecanam6”, means 
Virecana karma should adopt with Vatakapha hara 
dravyas. 
Role of Virecana in Tamaka Svasa 
 The origin of Svasa is pitta sthana. Chakrapani has 
narrated it as Adhoamashaya7 (Stomach), Virecana 
karma is the main treatment for Pitta dosha, 
“Virecanam pitta haranam8”.  
 Causing factor for the Tamaka svasa was Kapha and 
origin of the Kapha dosha is urdva Amasaya 
(stomach). Virecana is also supposed to be the 
secondary treatment for Kapha dosha.  
 Causes Anulomagati to Vata.  
So, if we give the Virecana chikitsa, both these 
doshas can be removed one by one (first Pitta followed 
by Kapha), Hence the Samprapti (pathogenesis) of the 
disease has broken.  
Keeping these aspects in mind the present study was 
carried out to evaluate the efficacy of Virecana karma 
in Tamaka svasa 
MATERIALS AND METHODS 
A. Preparation of the Drugs 
B. Selection of Patients 
C. Design of the study 
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D. Results and Discussion 
A. Preparation of the Drugs 
1. Murchana of Tilataila9 
4 litres of sesame oil was taken in an iron pan 
and heated till bubbles & waves disappear. Then the 
pan was removed from heat and allowed to cool at 
room temperature. 4 litres of above oil was taken in an 
iron pan and Manjista (Rubia cordifolia L.)- 250gm, 
Haridra (Curcuma longa L.)- 60gms, Lodhra 
(Symplocos racemosa Roxb.)- 60gms, Mustak (Cyperus 
rotundus Linn) - 60gms, Nalika- 60gms, Amalaki 
(Phyllanthus emblica Linn.)- 60gms, Haritaki 
(Terminalia chebula Retz.)- 60gms, Vibhitaki 
(Terminalia bellirica (Gaertn.) Roxb.)- 60gms, Ketaki 
(Pandanus odoratissimus Linn. f.)- 60gms, Vatankura 
(Ficus benghalensis Linn.)- 60gms & Hribera (Coleus 
vettiveroides K.C.Jacob)- 60gms and 16 litres of water 
were added. Then cook the preparation on fire till the 
water is completely evaporated, finally it was filtered. 
This oil was given for internal administration 
(snehapana). (Fig. 2) 
 2.Trivrutadi Modaka 
Trivrutadi Modaka was described in Caraka 
samhita, Kalpa sthana, 7th chapter under Modaka Yogas 
of Trivrut (Operculina turpethum). Three sana (7.5gms) 
of Trivrut churna was added with 1 sana (2.5gms) of 
the each powder of Haritaki pulp, Amalaki pulp, 
Vibhitaki pulp, Vidanga (Embelia ribes ), Pippali (Piper 
longum Linn) and Yava Kshara (alkali preparation of 
Hordem Vulgare Lin)). This powder was made into 
Modaka (a small round sweetmeat) with jaggery10 (Fig. 
3). This is an excellent purgative yoga and it does not 
require any diet restrictions.   
B. Selection of Patients 
For the present study, 30 patients of either sex 
fulfilling the clinical criteria for diagnosis of Tamaka 
Svasa (bronchial asthma) were selected in accordance 
with following inclusion & exclusion criteria, from the 
OPD & IPD of the P.G. department of Panchakarma, 
Dr.B.R.K.R. Govt. Ayurvedic Hospital and Research 
Centre, Erragadda, Hyderabad.  
Inclusion Criteria 
 Patients having classical features of Tamaka Svasa. 
 Belonging to age group 16 - 60 years.  
 Uncomplicated cases of Bronchial Asthma.  
Exclusion Criteria 
 The patients accompanying cardiac complaints.  
 Endocrine disorders like diabetes mellitus etc.  
 Patients suffering from Pulmonary tuberculosis, 
Lung Cancer, Lung fibrosis, Emphysema, 
Bronchiectasis, Cor-Pulmonale, IHD, Hypertension 
were excluded.  
 Other complicated respiratory diseases having any 
organic lesions such as tumour or any anatomical 
defect in airways.  
 Patients who are not able to tolerate Samshodhana 
(Purificatory) therapy are to be excluded. (children, 
old age, lean and week, pregnant women, lactating 
mothers)  
Diagnostic Criteria 
1.Cardinal Signs and symptoms of Tamaka Svasa are as 
mentioned in classics.  
2. Respiratory function tests like 
 Procedure to measure PEFR 
                The Peak flow meter (Fig. 1) was used to 
measure the PEFR. The patient was asked to take deep 
breath and then to blow hard in to the mouth piece of 
the peak flow meter with a sharp blast. The needle on 
the dial indicates the PEFR in litres per minute. Six 
readings were taken at 1 min intervals and the average 
of 4 higher readings was recorded, for the assessment 
before and after the treatment.  
 Procedure to measure Breath holding 
time(B.H.T) 
                The patient was asked to sit quietly for a few 
minutes and to breath normally, before the BHT 
exercises were started. The patient was asked to pinch 
his nostrils with the thumb and fore finger and hold his 
breath after a normal inspiration. The time for which 
the breath could be held was noted with stop-watch. 
Observations were made at intervals of 2 min, the best 
value was taken for the assessment before and after 
the treatment. 
3. Laboratory Investigations 
 Blood: Hb%, T.C., D.C., E.S.R, AEC.  
 Urine: Routine and Microscopic examination  
 Sputum: AFB (If necessary, to exclude T.B)  
 Radiology: X-Ray was done for ruling out other 
pulmonary complications. 
C. Design of the study 
The study design was randomized open 
clinical trial of over 30 cases of Tamaka svasa. The 
selected patients were treated by classical Virecana 
Karma with Trivrutadi Modaka. Classical Virecana 
Karma includes Dipana, Pachana, Snehapana, 
Abhyanga & Svedana, Shodhana and Samsarjana 
Krama. Patients are advised to follow Pathyadi krama 
(wholesome Ahara & Vihara). 
Abhyantara sneha pana (Internal administration of 
medicated oil) 
Murchita tilataila was administered daily in 
the morning, after sunrise in Vardhamana Krama 
(increasing dose),starting with Hrasiyasi Matra (Test 
dose), followed by warm water consumption. Patient 
was daily examined and assessed for Samayak Sneha 
Jirna Lakshanas. Snehapana was given till the Samayak 
Snigdha lakshanas were observed. 
Virecana (purgation therapy) 
After attaining of Samyak Snigdha lakshanas, 
the patient was subjected to Abhyanga (massage) 
along with bhaspa svedana (steam-bath) for 3 days. On 
the 4th day, Trivrutadi Modaka was given on empty 
stomach with warm water for Virecana. The dose 
varies according to Kostha and Agni (digestive power) 
of the patients.  
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Samsarjana krama  
Depending upon the type of Shuddhi (Laingiki, 
Vagiki and Antiki) shown by the patients, Samsarjana 
Krama was prescribed for 3-7days, followed by normal 
diet/ Pathya ahara. After completion of Samsarjana 
Krama, the patients were assessed for the effect of 
Virecana. 
Parameters with gradation Score 
1. Svasa vega (Frequency of Dyspnoea) 
0-No vega during 15 days.  
1-2 to 3 vegas within 15 days.  
2-2 to 3 vegas in a week.  
3-Frequent attack  
2. Kruchra Svasa (Intensity and duration of attack)  
0-No Svasa  
1-Mild breathlessness and attack lasts 10 min, do 
not require any medication.  
2-Moderate breathlessness, it lasts 30 min, after 
taking rest/mild medication.  
3-Severe breathlessness and it lasts more than 30 
min, resolution only after strong medication.  
3. Kasa (Cough) 
0-No Kasa  
1-Occasional Kasa vega.  
2-Kasa vega with some pain, not disturbing the 
sleep.  
3-Very troublesome Kasa, does not even allow to 
sleep at night.  
4. Pinasa (Rhinitis) 
0-No Pinasa  
1-Pinasa during the attack and subsides 1- 2 days 
after attack  
2-Very often Pinasa, even without attack  
3-Always Pinasa persisting.  
5. Parsvasula (Pain in inter-costal spaces) 
0-No parsvasula  
1-Parsvasula during the attack  
2-Very often parsvasula even without attack  
3-Always parsvasula (Persistent pain)  
6. Ghurghurakam (wheezing)  
0- No wheezing  
1-Wheezing only during attack  
2-Occasional wheezing.  
3-Very often Wheezing.  
7. Asino Labhate saukhyam (Relieves discomfort in 
sitting posture) 
0 -Relief in lying position  
1-Feels better in sitting posture  
2-Sitting posture gives relief. 
3-Can’t sleep, patient adopts spontaneous sitting 
posture during attack.  
8. Sleshma vimoksante muhurtam sukham (Comfort 
after the phlegm comes out) 
0-No relief even after phlegm comes out 
1-Comfort after the phlegm comes out during attack  
2-Very often comfort after the phlegm comes out 
3-Feels comfort after the phlegm comes out every 
time 
9. Anidra (Sleeplessness) 
0-Sound sleep  
1-Undisturbed late sleep  
2-Sleep disturbed at late night and early morning  
3-No sleep 
Functional assessment 
Functional tests like PEFR, Breath holding 
time, were carried out before and after the treatment.  
Follow- up study 
After the completion of the treatment, the 
follow up was taken once in a fortnight up to two 
months, to note the recovery of attacks and symptoms. 
Assessment of overall effect of the therapy 
Complete remission: 100% relief in signs and 
symptoms. No attack of svasa vega during and after the 
treatment up to two months of follow up.  
Marked relief: 75%-99% relief in signs and 
symptoms, the frequency and intensity of attacks were 
reduced to 75% of the initial one.  
Moderate relief:-50% to 75% relief in signs and 
symptoms, the frequency and intensity of attacks were 
reduced to 50% of the initial one. 
Mild relief: 25% to 50% relief in signs and symptoms, 
the frequency and intensity of attacks were reduced to 
25% of the initial one.  
No relief: Less than 25% relief in signs and symptoms, 
with no change in the frequency and intensity of 
attack. 
OBSERVATIONS 
In this present study majority of patients were 
between the age group of 20-30 years. It was observed 
that males were more affected than females. The 
higher incidence was observed during winter and 
rainy season. Among the chief complaints, Kruchra 
Svasa, Kasa, Pinasa were observed in all the 30 
patients (100%), Parsva sula in 20 patients (66.66%), 
Ghurghurakam in 26 patients (86.66%), Asinolabhate 
Soukhyam in 28 patients (93.33%), Sleshma 
vimokshante Muhutam sukham in 25 patients 
(83.33%), Anidra in 26 patients (86.66%).Among 
Samyak Virechan Lakshana, Laghuta was observed in 
100% of the patients, Indriya Prasada was observed in 
26 patients (86.66%), Vatanulomana was observed in 
28 patients (93.333%), Daurbalya was observed in 19 
Patients (63.33%). Virecana vyapaths (Complications) 
did not occur during the study. 3-4 kgs of weight 
reduction was also observed in all the cases. 
D. RESULTS AND DISCUSSION 
Effect of Virecana on Subjective Parameters 
The reduction in the frequency of Svasa vega 
was up to 54.68%, which was statistically highly 
significant (p<0.001). It implied that, by giving 
Virecana with Trivrutadi Modaka, the obstruction in 
the Pranavaha srotas was relieved and it may 
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strengthen the Pranavaha Srotas, there by frequency of 
Svasa vega was also reduced. 
Reduction in the intensity and duration of 
Svasa vega was up to 46.66%, which was statistically 
highly significant (p<0.001). In Svasa roga, the Dusta 
kapha obstructs the Prakupita vayu in Pranavaha 
srotas & this obstruction was relieved better by 
Trivrutadi Modaka, because it possess Katu, Tikta rasa, 
Laghu, Ushna, Tikshna properties. These pacify the 
Kapha and also produce Anuloma gati to Vata & purify 
the Pitta sthana by its Virecana karma. Hence, the 
Samprapti vighatana of Svasa vyadhi was happened. 
Therefore, the intensity and duration of Svasa vega 
was reduced. 
Kasa was relieved by 57.97%, this is 
statistically highly significant (P<0.001%), due to its 
Tridosha-hara, Ushnavirya, Kasasvasahara properties 
of the drug & the Srotorodha of the Pranavaha srotas 
was also removed by Virecana karma.  
Pinasa was relieved 63.88%, this is 
statistically highly Significant (P<0.001). The chief 
predominant Doshas in Pinasam is Vata & Kapha & 
both these factors were better managed by Virecana 
karma. The relief in Parsva sula was 76.74%, which is 
statistically highly Significant (P<0.001).  
Ghurghurakam was relieved by 55.55%, which 
is statistically highly significant (P<0.001). Generally, 
Ghurghurakam is produced due to obstruction of prana 
vayu by kapha & this is relieved better by ushna, 
tikshna properties of Trivrutadi modaka and by its 
Virecana karma.  
Asino labhate Soukhyam (Relieves discomfort 
in sitting posture) was relieved by 52.38%, which is 
statistically highly significant (P<0.001). In Svasa, due 
to Pitta sthana dusti, there is production of Aama 
rasadhatu & this causes excess secretion of dusta 
kapha in pranavaha srotas. On lying position, the Vayu 
get entrapped and is unable to escape. Secondly there 
is decrease in space for the movement of Pranavayu, 
because of ascending diaphragm. Hence it initiates the 
Svasa vega. The Virecana karma by its effect does the 
Shuddhi of Pitta sthana and Tikta, Katu rasa, Ushna 
virya of the drug corrects the rasa Dhatu dushti. 
Lekhana, Chedana, Kapha Nissaraka guna of Yava 
kshara clears the Srota rodha, by all these the Anuloma 
gati of Prana vayu was restored. 
Sleshma vimokshante labhate sukham was 
relieved by 54.83%, which is statistically highly 
Significant (P<0.001). In this study Murchita tilataila 
was given for Sneha pana, because of its Ushna guna, 
Tikshna, Vyavayi gunas, it breaks the sticky mucous, 
and facilitates its easy expulsion. Then by Virecana 
karma the remaining Kapha dosha was eliminated.  
       Anidrata was relieved by 48.07%, which is 
statistically highly significant (P<0.001). Sleep is 
disturbed due to continuous Kasa, dyspnoea. Once 
these are under control, patient will get proper sleep.   
Table 1: Showing effect of Virecana on Subjective Parameters 
S.No Symptom Mean % of 
Relief 
S.D SEm t-Value P-
Value 
Signifi
cance B.T A.T B.T A.T B.T A.T 
1.  Frequency of Svasa Vega 2.13 0.97 54.68% 0.57 0.41 0.10 0.08 13.857 <0.001 H.S 
2.  Kruchra Svasa 2.00 1.07 46.66% 0.83 0.58 0.15 0.11 6.9112 <0.001 H.S 
3.  Kasa 2.30 0.97 57.97% 0.65 0.49 0.12 0.09 8.9597 <0.001 H.S 
4.  Pinasa 2.40 0.87 63.88% 0.56 0.43 0.10 0.08 14.699 <0.001 H.S 
5.  Parswa sula 1.43 0.33 76.74% 1.01 0.55 0.18 0.10 5.2610 <0.001 H.S 
6.  Ghurghurakam 1.80 0.70 55.55% 1.03 0.65 0.19 0.12 7.9395 <0.001 H.S 
7.  Asino labhate Soukhyam 2.10 1.00 53.38% 0.80 0.53 0.15 0.10 8.4624 <0.001 H.S 
8.  Sleshma Vimokshante 
muhurtam sukham 
2.07 0.93 54.83% 1.08 0.69 0.20 0.13 7.2150 <0.001 H.S 
9.  Anidra 1.73 0.87 48.07% 0.91 0.63 0.17 0.11 8.3083 <0.001 H.S 
Effect of therapy on Objective parameters 
AEC was decreased by 27.95%, which was 
statistically significant (P<0.001). There was an 
increase in the P.E.F.R. by 34.25%, which was 
statistically highly significant (p<0.001).There was an 
increase in the B.H.T. by 32.69%, which was 
statistically highly significant (p<0.001).  
Table 2: Showing effect of Virecana on Objective Parameters 
S.N
o 
Para 
meter 
Mean % of 
Relief 
S.D SEm t-Value P-
Value 
Signifi
cance B.T A.T B.T A.T B.T A.T 
1.  A.E.C 543.57 391.63 28.00% 161.01 81.64 29.40 14.90 5.2178 <0.001 H.S 
2.  PEFR 205.33 312.33 34.25% 49.81 50.01 9.09 9.13 10.874 <0.001 H.S 
3.  BHT 19.77 29.37 32.69% 4.53 7.71 0.83 1.41 8.0373 <0.001 H.S 
(S.D:-Standard deviation,  S.Em- Mean of Standard Error, H.S:-Highly Significant, B.T-Before Treatment,  A.T:- 
After Treatment.) 
Discussion on overall effect of therapy 
There was moderate relief in 23 patients 
(76.66%), Marked relief in 4 patients (13.33%) and 3 
patients (10%) showed mild relief, Complete 
remission was not found. 
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Table 3: Showing overall effect of Therapy 
Results No. of 
patients 
Percentage 
Marked relief 04 13.33% 
Moderate relief 23 76.66% 
Mild relief 03 10.00% 
No relief 00 00 
Discussion on Follow-up Period 
Follow up was done for 2 months after 
completion of the therapy. In this period, the patient 
was kept under Pathya ahara and vihara (wholesome 
diet and activities) and assessment was done for every 
15 days. Out of 30 Patients, 10 Patients (33.33%) got 
recurrence of attack, but the frequency, Intensity, need 
of emergency medicine was reduced. The reason 
behind this may be due to chronicity of disease or 
failing in following the Pathya ahara / Nidana Sevana.  
CONCLUSION 
In the present study 30 patients fulfilling the 
inclusion criteria were selected and treated with 
Virecana Karma. The most common aetiological factors 
of Tamaka Svasa observed in this study are raja (Dust), 
Dhuma (smoke), kapha vardhaka ahara vihara and 
more Katu rasa sevana.  
Both subjective and objective parameters 
were improved and which were statistically highly 
significant (P<0.001). It was found that, moderate 
relief in 23 patients (76.66%), Marked relief in 4 
patients (13.33%) and 3 patients (10.00%) showed 
mild relief, Complete remission was not found. In 
follow up period, 10 Patients (33.33%) got recurrence 
attack, but the frequency, intensity, need of emergency 
medicine was reduced. The reason behind this may be 
due to Chronicity of disease or failing in following the 
Pathya ahara / Nidana Sevana. Hence, it can be 
concluded that, Virecana Karma with Trivrutadi 
Modaka found more effective in breaking the 
samprapti (pathogenesis) of Tamaka Svasa, thus the 
main goal of the chikitsa, i.e,“ Samprapti vighatana 
meva chikitsa” can be achieved. 
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